Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study

• Hoofdauteurs: Andrea Ticinesi (Auteur), Domenico Tuttolomondo (Auteur), Antonio Nouvenne (Auteur), Alberto Parise (Auteur), Nicoletta Cerundolo (Auteur), Beatrice Prati (Auteur), Ilaria Zanichelli (Auteur), Angela Guerra (Auteur), Nicola Gaibazzi (Auteur), Tiziana Meschi (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The benefits of remdesivir treatment, with or without co-administration of antibiotics such as azithromycin, are uncertain in COVID-19 pneumonia. The aim of this retrospective single-center study was to assess the effects of remdesivir, with or without azithromycin, on hospital mortality, intensive...